The benefit of direct oral anticoagulants on stroke risk in patients with prior intracerebral hemorrhage and atrial ...

One in six deaths from cardiovascular disease in the United States is due to stroke, and over 100 million people worldwide ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, 'Axana' ...

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

A new study suggests that a simple blood test could help doctors quickly determine whether a stroke is caused by bleeding or ...